However, when AKD was evaluated incorporating Cystatin C, a more stable biomarker of glomerular filtration in the context of SCA, and markers of structural kidney injury were incorporated (i.e., macroalbuminuria, positive NGAL), AKD was identified as a risk factor for sMBD. This evidence concerns the gene CST3 and autosomal dominant cerebellar ataxia.